Filter
4368
Text search:
new
medicines
Featured
Recommendations
468
New Publications
1170
Language
Document type
No document type
2238
Studies & Reports
764
Guidelines
624
Manuals
262
Strategic & Response Plan
216
Training Material
82
Fact sheets
78
Situation Updates
55
Infographics
17
Brochures
14
Resource Platforms
14
Online Courses
3
Videos
1
Countries / Regions
India
215
Global
206
Kenya
131
Uganda
109
South Africa
101
Ethiopia
92
Nepal
85
Sierra Leone
80
Liberia
79
Western and Central Europe
79
Africa
76
Nigeria
73
Tanzania
72
Myanmar / Burma
69
Zambia
67
Malawi
66
Latin America and the Carribbean
65
Bangladesh
63
Ghana
61
Ukraine
58
Rwanda
48
Namibia
47
Syria
43
Eastern Europe
34
Congo, Democratic Republic of
33
Philippines
33
South–East Asia Region
33
Zimbabwe
32
Asia
30
Venezuela
30
Mozambique
25
Haiti
24
Cambodia
22
Lesotho
22
Guinea
21
South Sudan
19
Indonesia
19
Yemen
19
East and Southern Africa
19
Burkina Faso
18
Senegal
18
West and Central Africa
18
Middle East and North Africa
17
Russia
17
Brazil
15
Botswana
15
Eastern Europe and Central Asia
15
Pakistan
13
Cameroon
12
Eswatini/ Swaziland
12
Madagascar
12
Sudan
11
North America
11
Afghanistan
10
Somalia
9
Thailand
9
Western Pacific Region
9
Germany
8
Lebanon
8
Colombia
8
Moldova
8
Vietnam
8
Central African Republic
7
Peru
7
Georgia
7
Jordan
6
China
6
Laos
6
Tajikistan
6
Mali
5
Iraq
5
Benin
5
North Macedonia
5
Bolivia
5
Paraguay
5
Poland
5
Palestine
5
Albania
5
Côte d’Ivoire / Ivory Coast
4
Hungary
4
Ecuador
4
El Salvador
4
Mexico
4
Bhutan
4
Southern Africa
4
Iran
4
United Kingdom
4
Morocco
3
Saudi Arabia
3
Niger
3
Egypt
3
Papua New Guinea
3
Argentina
3
Libya
3
Sri Lanka
3
Timor Leste/ East Timor
3
Romania
3
Jamaica
3
USA
2
Turkey
2
Chad
2
Gambia
2
Switzerland
2
Serbia
2
Honduras
2
Angola
2
Guatemala
2
Nicaragua
2
Chile
2
Canada
2
Qatar
2
Bulgaria
2
Kyrgyzstan
2
Australia
2
Gabon
2
Turkmenistan
2
Japan
2
Mauritius
2
Tunisia
2
Guinea-Bissau
1
Togo
1
Dominican Republic
1
Burundi
1
Greece
1
Other region
1
Fiji
1
Solomon Islands
1
Djibouti
1
Armenia
1
Mongolia
1
Congo-Brazzaville
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Kazakhstan
1
Uruguay
1
Denmark
1
France
1
Maldives
1
Norway
1
Portugal
1
Spain
1
Belarus
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
1725
Clinical Guidelines
401
Public Health
257
Women & Child Health
191
Key Resources
160
Capacity Building
86
Pharmacy & Technologies
54
Annual Report MEDBOX
2
Toolboxes
HIV
383
COVID-19
307
TB
290
Mental Health
268
AMR
242
Pharmacy
173
NTDs
121
NCDs
121
Caregiver
114
Conflict
106
Disability
91
Ebola & Marburg
87
Malaria
85
Planetary Health
81
Global Health Education
69
Rapid Response
60
Refugee
60
Health Financing Toolbox
58
Natural Hazards
44
2.0 Rapid Response
25
Zika
16
Cholera
14
Polio
11
Specific Hazards
10
Social Ethics
6
Typhoon
1
Breakthrough innovations have come to light that have proved to be more than 95% effective in preventing HIV infection with injections just twice a year. Once a year might even be possible. They could also be key for 40 million people living with HIV around the world who need better options for trea
...
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing h
...
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
DOI: 10.5772/intechopen.102891Little progress has been made since the 1960s and 19. 70s to widen the therapeutic arsenal against Trypanosoma cruzi, the causative pathogen of Chagas disease, which remains a frustrating and perplexing infectious disease. This chapter focuses on the strategic and opera
...
The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration t
...
The Priority medicines for mothers and children 2011 list was updated following the 18th Expert Committee Meeting
on Selection and Use of Medicines, the release of
...
Traditional medicine, including the knowledge, skills and practices of holistic health care, exists in all cultures. It is based on indigenous theories, beliefs and experiences and is widely accepted for its role in health maintenance and the treatment of disease.Medicinal plants are the main ingred
...
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essen
...
100 test methods for 100 active pharmaceutical ingredients
For existing Minilab projects that want to replace old manuals or initiatives that want to start new projects, the new "Minilab Edition 20
...
Africa’s health sector is facing an unprecedented financing crisis, driven by a sharp decline of 70% in Official Development Assistance (ODA) from 2021 to 2025 and deep-rooted structural vulnerabilities. This collapse is placing immense pressure on Africa’s already fragile health systems as ODA
...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is
...
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essen
...
Chemoprevention is the use of medicines, either alone or in combination, to prevent malaria infection and its consequences. This publication provides standardized approaches for monitoring and evaluating the efficacy of
...
WHO has developed a new health kit to support treatment for chronic disease patients in emergency settings. The prevalence of NCDs is increasing worldwide, including in emergency/crisis-prone areas. Yet current humanitarian response has not accounte
...